Meet the Experts Breakfast Session

Saturday, September 13, 2003
7:15am–8:00am
Ballroom 20B-D

Symposium attendees will be able to join highly interactive discussions about breast cancer topics that have implications for performing research and living with the disease. Informal small group discussions will be led by experts in the field.

Bradley Arrick, M.D., Ph.D.
Risk Assessment and Genetic Testing for Breast Cancer (29kB .PDF)
Bradley Arrick is the Medical Director of the Familial Cancer Program at the Norris Cotton Cancer Center, Dartmouth Hitchcock Medical Center, and a practicing breast cancer oncologist. One of his research interests is the function of the breast cancer ovarian susceptibility gene, BRCA1. He will lead a discussion on the opportunities and pitfalls in genetic testing and in determining breast cancer risk.

Barbara Brenner
Making Your Voice Heard—Breast Cancer Advocacy
Barbara Brenner has been an activist since her diagnosis of breast cancer at 41. She is the Executive Director of Breast Cancer Action, a national education and advocacy organization committed to carrying “the voices of people affected by breast cancer to inspire and compel the changes necessary to end the breast cancer epidemic.” Ms. Brenner will lead a discussion about how advocacy can inform research and turn issues of concern to the communities into political action.

Beverley Burns, M.S., L.Ac.
Approaches for Researching Alternative Medicines
Beverly Burns is a practitioner of TCM (traditional Chinese medicine) and co-founded the Charlotte Maxwell Complementary Clinic, which provides services to low income women. She is also part of a multidisciplinary team performing breast cancer research at UCSF Cancer Center. She will lead a discussion about alternative medicines and how they can be realistically analyzed for effectiveness.

Catherine Carpenter, Ph.D.
Exercise and Breast Cancer (1548 kB .PDF)
Catherine Carpenter is an Assistant Professor of Medicine at the University of California, Los Angeles, who co-authored a pivotal paper about the influence of exercise and body weight on the development of breast cancer. She will lead a discussion on the scientific basis and practical issues of using exercise to reduce breast cancer risk.

Mhel Kavanaugh-Lynch, M.D., M.P.H.
CBCRP, The Next Decade
Mhel Kavanaugh-Lynch has been the director of CBCRP for eight years. She will be available to discuss the current goals and the future directions of CBCRP in the next decade, or any other issues you bring to her.

Malcolm Pike, Ph.D.
Hormones and Breast Cancer (240 kB .PDF)
Malcolm Pike is a professor at the University of Southern California. He has researched the regulation of hormones and their relationship to the development and prevention of breast cancer. He will lead a discussion of the influence of hormones produced by and introduced into the body on breast cancer cause and risk reduction.

Hope Rugo, M.D.
Current Breast Cancer Clinical Trials (144 kB .PDF)
Hope Rugo is a practicing breast cancer oncologist and clinical researcher at the University of California, San Francisco. Dr. Rugo is the principal investigator of several regional and national clinical trials focusing on using novel agents, combinations of agents, or vaccines to treat advanced breast cancer. She will lead a discussion on the promising clinical trials that are being undertaken to combat the disease.

Anne Wallace, M.D.
Clinical Trial Recruitment—the National Surgical Breast and Prevention Trial
Anne Wallace is the director of UCSD Cancer Center’s Breast Care Unit. She is a practicing breast cancer surgeon and a principal investigator on the National Surgical Breast and Prevention trial (NSABP), which among other accomplishments led to the establishment of lumpectomy plus radiation over radical mastectomy as the standard surgical treatment for breast cancer. She will lead a discussion on the experience of the NSABP and issues involved in clinical trial recruitment.